Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-03 | Vir Biotechnology, Inc. | De Backer Marianne
(Chief Executive Officer) |
S | Common Stock | D | 72995 | $9.46 - $9.46 | $690,364 |
| 2024-04-01 | Vir Biotechnology, Inc. | HANLY ANN M.
(EVP & Chief Technology Officer) |
S | Common Stock | D | 2711 | $10.05 - $10.05 | $27,250 |
| 2024-03-27 | Vir Biotechnology, Inc. | Lee Sung
(EVP & Chief Financial Officer) |
S | Common Stock | D | 6008 | $9.89 - $9.89 | $59,404 |
| 2024-02-22 | Vir Biotechnology, Inc. | HANLY ANN M.
(EVP & Chief Technology Officer) |
S | Common Stock | D | 12296 | $10.05 - $10.05 | $123,520 |
| 2024-02-22 | Vir Biotechnology, Inc. | HANLY ANN M.
(EVP & Chief Technology Officer) |
A | Common Stock | A | 32500 | $0.00 - $0.00 | $0 |
| 2024-02-22 | Vir Biotechnology, Inc. | De Backer Marianne
(Chief Executive Officer) |
A | Common Stock | A | 175000 | $0.00 - $0.00 | $0 |
| 2024-02-22 | Vir Biotechnology, Inc. | Lee Sung
(EVP & Chief Financial Officer) |
A | Common Stock | A | 40000 | $0.00 - $0.00 | $0 |
| 2024-02-22 | Vir Biotechnology, Inc. | Pang Phillip
(EVP & Chief Medical Officer) |
S | Common Stock | D | 14568 | $10.05 - $10.05 | $146,344 |
| 2024-02-22 | Vir Biotechnology, Inc. | SCANGOS GEORGE A
(Director) |
S | Common Stock | D | 27750 | $10.05 - $11.65 | $307,258 |
| 2024-02-16 | Vir Biotechnology, Inc. | SCANGOS GEORGE A
(Director) |
S | Common Stock | D | 27750 | $10.22 - $10.24 | $283,770 |
| 2024-02-16 | Vir Biotechnology, Inc. | Pang Phillip
(EVP & Chief Medical Officer) |
S | Common Stock | D | 3321 | $10.24 - $10.24 | $34,005 |
| 2024-01-02 | Vir Biotechnology, Inc. | Pang Phillip
(EVP & Chief Medical Officer) |
M | Common Stock | A | 80000 | $0.85 - $1.57 | $110,298 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |